Ken Sugimoto

5.9k total citations · 1 hit paper
174 papers, 4.0k citations indexed

About

Ken Sugimoto is a scholar working on Surgery, Epidemiology and Genetics. According to data from OpenAlex, Ken Sugimoto has authored 174 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Surgery, 51 papers in Epidemiology and 47 papers in Genetics. Recurrent topics in Ken Sugimoto's work include Inflammatory Bowel Disease (47 papers), Helicobacter pylori-related gastroenterology studies (44 papers) and Microscopic Colitis (35 papers). Ken Sugimoto is often cited by papers focused on Inflammatory Bowel Disease (47 papers), Helicobacter pylori-related gastroenterology studies (44 papers) and Microscopic Colitis (35 papers). Ken Sugimoto collaborates with scholars based in Japan, United States and South Korea. Ken Sugimoto's co-authors include Hiroyuki Hanai, Atsushi Mizoguchi, Yasuyo Shimomura, Takahisa Furuta, Emiko Mizoguchi, Satoshi Osawa, Atul K. Bhan, Atsuhiro Ogaẃa, Akira Andoh and Ramnik J. Xavier and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Ken Sugimoto

167 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis

2008 855 citations Ken Sugimoto, Atsuhiro Ogaẃa et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken Sugimoto Japan	30	1.4k	1.3k	1.1k	752	707	174	4.0k
Giuseppe Sica Italy	36	1.2k 0.9×	932 0.7×	833 0.8×	980 1.3×	246 0.3×	139	4.0k
Yohei Mizuta Japan	35	1.4k 1.0×	414 0.3×	271 0.3×	579 0.8×	915 1.3×	162	4.0k
Jacques Devière Belgium	29	1.1k 0.8×	949 0.7×	277 0.3×	463 0.6×	295 0.4×	74	3.8k
Fachao Zhi China	37	1.2k 0.9×	543 0.4×	519 0.5×	1.8k 2.4×	467 0.7×	116	4.0k
Laurence J. Egan Ireland	35	1.6k 1.1×	2.0k 1.5×	2.5k 2.4×	1.8k 2.4×	530 0.7×	83	7.2k
Ivan Monteleone Italy	39	700 0.5×	2.1k 1.6×	1.5k 1.5×	1.5k 2.0×	451 0.6×	101	4.7k
Jonas Mudter Germany	26	840 0.6×	1.4k 1.1×	1.4k 1.3×	550 0.7×	219 0.3×	71	3.7k
Yoshihiro Hirata Japan	41	2.3k 1.6×	1.3k 1.0×	366 0.3×	1.3k 1.7×	574 0.8×	160	4.9k
Taku Kobayashi Japan	36	996 0.7×	1.8k 1.4×	2.6k 2.4×	1.4k 1.9×	333 0.5×	161	5.3k
Alfredo Papa Italy	36	1.4k 1.0×	673 0.5×	1.9k 1.8×	493 0.7×	340 0.5×	161	3.9k

Countries citing papers authored by Ken Sugimoto

Since Specialization

Citations

This map shows the geographic impact of Ken Sugimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Sugimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Sugimoto more than expected).

Fields of papers citing papers by Ken Sugimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Sugimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Sugimoto. The network helps show where Ken Sugimoto may publish in the future.

Co-authorship network of co-authors of Ken Sugimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Sugimoto. A scholar is included among the top collaborators of Ken Sugimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Sugimoto. Ken Sugimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horiuchi, Akira, et al.. (2025). Geboes Histopathology Score Grade 3 Subclassification Predicts Treatment Response in Active Ulcerative Colitis. Journal of Clinical Medicine. 14(20). 7214–7214.

Meguro, Shiori, Hideya Kawasaki, Isao Kosugi, et al.. (2024). A Case of Brunner’s Gland Hyperplasia Accompanied by an Increase in Endocrine Cells and Endocrine Cell Micronests. Cureus. 16(9). e68688–e68688. 1 indexed citations

Takahashi, Kenichi, Yusuke Asai, Satoshi Tamura, et al.. (2024). Albumin change predicts failure in ulcerative colitis treated with adalimumab. PLoS ONE. 19(1). e0295681–e0295681. 1 indexed citations

Gao, Xiang, Toshimitsu Fujii, Byong Duk Ye, et al.. (2023). Efficacy and safety of risankizumab for Crohn's disease in patients from Asian countries: a post hoc subanalysis of the global phase 3 ADVANCE, MOTIVATE, and FORTIFY studies. Journal of Gastroenterology and Hepatology. 39(1). 55–65. 9 indexed citations

Furuta, Takahisa, Mihoko Yamade, Satoru Takahashi, et al.. (2023). Expectations for the Dual Therapy with Vonoprazan and Amoxicillin for the Eradication of H. pylori. Journal of Clinical Medicine. 12(9). 3110–3110. 7 indexed citations

Yamade, Mihoko, Satoru Takahashi, Satoshi Tamura, et al.. (2022). Influence of daily versus alternate-day dosing of vonoprazan on intragastric pH, serum gastrin, and the antiplatelet function of clopidogrel. European Journal of Clinical Pharmacology. 78(6). 955–963. 1 indexed citations

Suzuki, Takahiro, Takuma Kagami, Takahiro Uotani, et al.. (2021). Effects of pirenzepine on vonoprazan-induced gastric acid inhibition and hypergastrinemia. European Journal of Clinical Pharmacology. 77(7). 971–978. 8 indexed citations

Ohashi, Naro, Mitsushige Sugimoto, Hitomi Ichikawa, et al.. (2018). Gender Differences in Plasma Ghrelin Levels in Hemodialysis Patients. Therapeutic Apheresis and Dialysis. 23(1). 65–72. 4 indexed citations

Furuta, Takahisa, S. Baba, Mihoko Yamade, et al.. (2018). High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication. Alimentary Pharmacology & Therapeutics. 48(3). 370–377. 40 indexed citations

10.

Imaizumi, Yuki, Yoichi Takami, Kōichi Yamamoto, et al.. (2018). Pathophysiological significance of cylindromatosis in the vascular endothelium and macrophages for the initiation of age-related atherogenesis. Biochemical and Biophysical Research Communications. 508(4). 1168–1174. 3 indexed citations

11.

Suzuki, Satoshi, Moriya Iwaizumi, Stephanie Tseng-Rogenski, et al.. (2016). Production of truncated MBD4 protein by frameshift mutation in DNA mismatch repair-deficient cells enhances 5-fluorouracil sensitivity that is independent ofhMLH1status. Cancer Biology & Therapy. 17(7). 760–768. 8 indexed citations

12.

Furuta, Takahisa, Yoshihiro Soya, Mitsushige Sugimoto, et al.. (2013). Rapid Automated Genotyping of CYP2C19 and Helicobacter pylori 23S rRNA Gene in Gastric Juice. Journal of Gastroenterology and Hepatology Research. 2(4). 508–512. 12 indexed citations

13.

Yamade, Mihoko, Mitsushige Sugimoto, Masafumi Nishino, et al.. (2012). Trastuzumab has opposing effects on SN-38-induced double-strand breaks and cytotoxicity in HER2-positive gastric cancer cells depending on administration sequence.. PubMed. 32(1). 105–14. 7 indexed citations

14.

Hanai, Hiroyuki & Ken Sugimoto. (2009). Curcumin has Bright Prospects for the Treatment of Inflammatory Bowel Disease. Current Pharmaceutical Design. 15(18). 2087–2094. 134 indexed citations

15.

Sugimoto, Ken, Atsuhiro Ogaẃa, Emiko Mizoguchi, et al.. (2008). IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. Journal of Clinical Investigation. 118(2). 534–44. 855 indexed citations breakdown →

16.

Mizoguchi, Atsushi, Hidetoshi Takedatsu, Ken Sugimoto, et al.. (2007). Dependence of intestinal granuloma formation on unique myeloid DC-like cells. Journal of Clinical Investigation. 117(3). 605–615. 37 indexed citations

17.

Nanno, Masanobu, Yasuyoshi Kanari, Tomoaki Naito, et al.. (2007). Exacerbating Role of γδ T Cells in Chronic Colitis of T-Cell Receptor α Mutant Mice. Gastroenterology. 134(2). 481–490. 45 indexed citations

18.

Nagahama, Kiyotaka, et al.. (2007). Protein Kinase C θ Plays a Fundamental Role in Different Types of Chronic Colitis. Gastroenterology. 134(2). 459–469. 32 indexed citations

19.

Kashiwagi, Masashi, et al.. (2004). An Analysis System for Propulsive Performance in Waves. 67–82. 23 indexed citations

20.

Utsunomiya, Takao, Ken Sugimoto, Chobin MAKABE, & Kunihiro Iida. (2001). Fretting Fatigue Properties and Detection of Crack Initiation of Inconel Alloy.. Journal of the Society of Materials Science Japan. 50(7). 758–763. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact